Natural Killer cells from long-term non-progressor HIV patients are characterized by altered phenotype and function

Clinical Immunology

Volumn 124, Issue 3, 2007, Pages 277-283

  O'Connor, Geraldine M ^a   Holmes, Andrea ^b   Mulcahy, Fiona ^c   Gardiner, Clair M ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF TEXAS   (United States)

^c ST JAMES S HOSPITAL   (Ireland)

Author keywords

Cytotoxicity; HIV; Long term non progression; Natural killer cells

Indexed keywords

ARTICLE; CELL ACTIVITY; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNE SYSTEM; NATURAL KILLER CELL; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; VIRUS REPLICATION;

CYTOTOXICITY, IMMUNOLOGIC; DISEASE PROGRESSION; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; PHENOTYPE; RECEPTORS, IMMUNOLOGIC;

EID: 34547841649     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.05.016     Document Type: Article

References (23)

1. French A.R., and Yokoyama W.M. Natural killer cells and viral infections. Curr. Opin. Immunol. 15 (2003) 45-51
2. Biassoni R., Cantoni C., Pende D., Sivori S., Parolini S., Vitale M., Bottino C., and Moretta A. Human natural killer cell receptors and co-receptors. Immunol. Rev. 181 (2001) 203-214
3. Oliva A., Kinter A.L., Vaccarezza M., Rubbert A., Catanzaro A., Moir S., Monaco J., Ehler L., Mizell S., Jackson R., Li Y., Romano J.W., and Fauci A.S. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J. Clin. Invest. 102 (1998) 223-231
4. Scott-Algara D., Truong L.X., Versmisse P., David A., Luong T.T., Nguyen N.V., Theodorou I., Barre-Sinoussi F., and Pancino G. Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users. J. Immunol. 171 (2003) 5663-5667
5. Costa P., Rusconi S., Mavilio D., Fogli M., Murdaca G., Pende D., Mingari M.C., Galli M., Moretta L., and De Maria A. Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes. Aids 15 (2001) 965-974
6. Kottilil S., Shin K., Planta M., McLaughlin M., Hallahan C.W., Ghany M., Chun T.W., Sneller M.C., and Fauci A.S. Expression of chemokine and inhibitory receptors on natural killer cells: effect of immune activation and HIV viremia. J. Infect. Dis. 189 (2004) 1193-1198
7. Mavilio D., Benjamin J., Daucher M., Lombardo G., Kottilil S., Planta M.A., Marcenaro E., Bottino C., Moretta L., Moretta A., and Fauci A.S. Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 15011-15016
8. Easterbrook P.J. Long-term non-progression in HIV infection: definitions and epidemiological issues. J. Infect. 38 (1999) 71-73
9. Geffin R., Wolf D., Muller R., Hill M.D., Stellwag E., Freitag M., Sass G., Scott G.B., and Baur A.S. Functional and structural defects in HIV type 1 nef genes derived from pediatric long-term survivors. AIDS Res. Hum. Retroviruses 16 (2000) 1855-1868
10. den Uyl D., van der Horst-Bruinsma I.E., and van Agtmael M. Progression of HIV to AIDS: a protective role for HLA-B27?. AIDS Rev. 6 (2004) 89-96
11. Altfeld M., Addo M.M., Rosenberg E.S., Hecht F.M., Lee P.K., Vogel M., Yu X.G., Draenert R., Johnston M.N., Strick D., Allen T.M., Feeney M.E., Kahn J.O., Sekaly R.P., Levy J.A., Rockstroh J.K., Goulder P.J., and Walker B.D. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. Aids 17 (2003) 2581-2591
12. Huang Y., Paxton W.A., Wolinsky S.M., Neumann A.U., Zhang L., He T., Kang S., Ceradini D., Jin Z., Yazdanbakhsh K., Kunstman K., Erickson D., Dragon E., Landau N.R., Phair J., Ho D.D., and Koup R.A. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2 (1996) 1240-1243
13. Martin M.P., Gao X., Lee J.H., Nelson G.W., Detels R., Goedert J.J., Buchbinder S., Hoots K., Vlahov D., Trowsdale J., Wilson M., O'Brien S.J., and Carrington M. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31 (2002) 429-434
14. + natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2886-2891
15. Tarazona R., Casado J.G., Delarosa O., Torre-Cisneros J., Villanueva J.L., Sanchez B., Galiani M.D., Gonzalez R., Solana R., and Pena J. Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals. J. Clin. Immunol. 22 (2002) 176-183
16. De Maria A., Fogli M., Costa P., Murdaca G., Puppo F., Mavilio D., Moretta A., and Moretta L. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur. J. Immunol. 33 (2003) 2410-2418
17. Katz J.D., Mitsuyasu R., Gottlieb M.S., Lebow L.T., and Bonavida B. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex: II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity. J. Immunol. 139 (1987) 55-60
18. + cells in sexually HIV-1-exposed but uninfected individuals. Clin. Immunol. 120 (2006) 138-146
19. Alter G., Malenfant J.M., Delabre R.M., Burgett N.C., Yu X.G., Lichterfeld M., Zaunders J., and Altfeld M. Increased natural killer cell activity in viremic HIV-1 infection. J. Immunol. 173 (2004) 5305-5311
20. Kottilil S., Shin K., Jackson J.O., Reitano K.N., O'Shea M.A., Yang J., Hallahan C.W., Lempicki R., Arthos J., and Fauci A.S. Innate immune dysfunction in HIV infection: effect of HIV envelope-NK cell interactions. J. Immunol. 176 (2006) 1107-1114
21. Beattie T., Rowland-Jones S., and Kaul R. HIV-1 and AIDS: what are protective immune responses?. J. HIV Ther. 7 (2002) 35-39
22. Lopalco L. Humoral immunity in HIV-1 exposure: cause or effect of HIV resistance?. Curr. HIV Res. 2 (2004) 127-139
23. De Maria A., Ferraris A., Guastella M., Pilia S., Cantoni C., Polero L., Mingari M.C., Bassetti D., Fauci A.S., and Moretta L. Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 10285-10288